The product Breyna (NDC 0378-7502) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 4 unique RxNorm concepts. By anchoring Mylan Pharmaceuticals Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.
The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 0378-7502 to RxCUI 1246288, 1246304, 2597670, 2597673, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.
The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:
* Please review the full disclaimer at the bottom of this page.
